South America Injection Pen Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
The South America injection pen market is expected to grow from US$ 2,389.84 million in 2022 to US$ 3,467.89 million by 2028. It is estimated to register a CAGR of 6.4% from 2022 to 2028.
Increase in Strategic Developments in South America Injection Pen Market
The injection pen market is characterized by the presence of various market players. To increase their market share, market players take up various strategies such as product launches, regional expansion, and technological advancements. Leading players invest in R&D to develop advanced technologies and gain more revenue.
A few recent developments related to injection pens are mentioned below:
In May 2022, FDA approved Lilly's Mounjaro injection, the first and only glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes in adults. Mounjaro is available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) and comes in Lilly's well-established auto-injector pen with a pre-attached, hidden needle.
In January 2022, SHL Medical partnered with Innovation Zed for connected pen injector solutions. It launched InsulCheck DOSE, a connected add-on device that transforms traditional pen injectors into smart solutions to support the monitoring of disease management regimens.
In May 2021, Lilly collaborated internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes. The company signed strategic international agreements with four companies—DexCom, Inc.; Glooko Inc.; myDiabby Healthcare; and Roche—to advance connected solutions and streamline care for people suffering from diabetes.
Therefore, all the above-mentioned recent developments are driving the South America injection pen market.
South America Injection Pen Market Overview
The injection pen market in South America is segmented into Brazil, Argentina, and the Rest of South America. Growth of the South America injection pen market is attributed to the increasing incidence of diabetes and infertility and product development activities undertaken by major market players. According to the International Diabetes Federation (IDF), ~16.8 million people aged 20–79 have diabetes, and the number is expected to increase by 55% by 2045. ~90% of all diabetes diagnoses are type 2 diabetes. Further, according to the IDF, children and adolescents in Brazil aged 0–14 rank third in the global panorama of type 1 diabetes, with 55,500 cases. BIOMM, a biopharmaceutical company headquartered in Brazil, is the fourth-largest producer of insulin in the world; it is the largest producer in the country. In July 2021, BIOMM announced signing a commercialization agreement with Nemera to market the Advapen reusable pen injector for the treatment of diabetes with the Glargilin insulin. BIOMM will market the product under the trade name Lifepen in the Brazilian market.
South America Injection Pen Market Revenue and Forecast to 2028 (US$ Million)
The South America injection pen market is segmented on the basis of type, therapy, end user, and country. Based on type, the injection pen market is segmented into disposable injection pens and reusable injection pens. The disposable injection pens segment registered a larger market share in 2022.
Based on therapy, the South America injection pen market is segmented into diabetes therapy, growth hormone therapy, autoimmune diseases therapy, fertility therapy, cancer therapy, and others. The diabetes therapy segment registered the largest market share in 2022.
Based on end user, the South America injection pen market is segmented into hospitals & clinics, home care, and others. The home care segment registered the largest market share in 2022.
Based on country, the South America injection pen market is segmented into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market in 2022.
AstraZeneca Plc, Becton Dickinson and Co, Eli Lilly and Co, Gerresheimer AG, Haselmeier GmbH, Merck KGaA, Novo Nordisk AS, Owen Mumford Ltd, Sanofi SA, and Teva Pharmaceutical Industries Ltd are among the leading companies operating in the South America injection pen market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South America Injection Pen Market – by Type
1.3.2 South America Injection Pen Market – by Therapy
1.3.3 South America Injection Pen Market – by End User
1.3.4 South America Injection Pen Market – by Country
2. South America Injection Pen Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South America Injection Pen Market – Market Landscape
4.1 Overview
4.2 South America PEST Analysis
4.3 Expert’s Opinion
5. South America Injection Pen Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Disorders
5.1.2 Increase in Strategic Developments
5.2 Market Restraints
5.2.1 Presence of Alternative Drug Delivery Devices and Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Increase in Biologics Patent Expiry and Use of Biosimilars
5.4 Future Trends
5.4.1 Technological Advancements and Healthcare Waste Reduction
5.5 Impact Analysis
6. Injection Pen Market – South America Analysis
6.1 South America Injection Pen Market Revenue Forecast and Analysis
7. South America Injection Pen Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 South America Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Disposable Injection Pens
7.3.1 Overview
7.3.2 Disposable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Reusable Injection Pens
7.4.1 Overview
7.4.2 Reusable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8. South America Injection Pen Market Analysis and Forecast to 2028 – by Therapy
8.1 Overview
8.2 South America Injection Pen Market, by Therapy 2021 & 2028 (%)
8.3 Diabetes Therapy
8.3.1 Overview
8.3.2 Diabetes Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Growth Hormone Therapy
8.4.1 Overview
8.4.2 Growth Hormone Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Autoimmune Diseases Therapy
8.5.1 Overview
8.5.2 Autoimmune Diseases Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Fertility Therapy
8.6.1 Overview
8.6.2 Fertility Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Cancer Therapy
8.7.1 Overview
8.7.2 Cancer Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Other Therapies
8.8.1 Overview
8.8.2 Other Therapies: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9. South America Injection Pen Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 South America Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Home Care
9.3.1 Overview
9.3.2 Home Care: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals & Clinics
9.4.1 Overview
9.4.2 Hospitals & Clinics: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10. South America Injection Pen Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 South America: Injection Pen Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.4 Brazil: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.1.5 Brazil: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Argentina: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.4 Argentina: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.2.5 Argentina: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 Rest of South America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of South America: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.4 Rest of South America: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.3.5 Rest of South America: Injection Pen Market, by End User, 2019–2028 (US$ Million)
11. South America Injection Pen Market – Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Eli Lilly and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Owen Mumford Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sanofi SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Haselmeier GmbH
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Gerresheimer AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Becton Dickinson and Co
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 AstraZeneca Plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Teva Pharmaceutical Industries Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. Rest of South America Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of South America Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of South America Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Inorganic Growth Strategies in the Injection Pen Market
Table 12. Recent Organic Growth Strategies in the Injection Pen Market
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. South America Injection Pen Market Segmentation
Figure 2. South America Injection Pen Market, by Country
Figure 3. South America Injection Pen Market Overview
Figure 4. South America Injection Pen Market, by Type
Figure 5. South America Injection Pen Market, by Country
Figure 6. South America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South America Injection Pen Market: Impact Analysis of Drivers and Restraints
Figure 9. South America Injection Pen Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. South America Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Disposable Injection Pens: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Reusable Injection Pens: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. South America Injection Pen Market, by Therapy 2021 & 2028 (%)
Figure 14. Diabetes Therapy: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Growth Hormone Therapy: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Autoimmune Diseases Therapy: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Fertility Therapy: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer Therapy: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Therapies: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. South America Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)
Figure 21. Home Care: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Hospitals & Clinics: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. South America: Injection Pen Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. Brazil: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Argentina: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of South America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
- AstraZeneca Plc
- Becton Dickinson and Co
- Eli Lilly and Co
- Gerresheimer AG
- Haselmeier GmbH
- Merck KGaA
- Novo Nordisk AS
- Owen Mumford Ltd
- Sanofi SA
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America injection pen market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America injection pen market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the injection pen market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution